![George Ludwig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
George Ludwig
Corporate Officer/Principal presso ConPharm Anstalt
Profilo
Mr. Georg Ludwig is Managing Limited Partner at HighTech Private Equity GmbH
George Ludwig has been a Managing Director of ConPharm Anstalt since 2005 and a Director of Lorus Therapeutics, Inc. since September 2006.
Previously, he was a Managing Director of HighTech Private Equity from 2000 to 2004.
Posizioni attive di George Ludwig
Società | Posizione | Inizio |
---|---|---|
ConPharm Anstalt | Corporate Officer/Principal | 01/01/2005 |
Precedenti posizioni note di George Ludwig
Società | Posizione | Fine |
---|---|---|
High Tech Private Equity GmbH
![]() High Tech Private Equity GmbH Investment ManagersFinance High Tech Private Equity GmbH (HTPE) is a leading German private equity firm controlled by Triginta Capital Group GmbH (formerly AVIDA Equity Partners) and DEWB AG. Established in 1999 and based in Düsseldorf with an office in Liechtenstein, HTPE invests in rapidly growing technology companies and manages the High Tech Beteiligungen fund, backed by institutional investors including German pension funds, banks and insurance companies. | Corporate Officer/Principal | 01/01/2004 |
APTOSE BIOSCIENCES INC. | Direttore/Membro del Consiglio | 03/03/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
APTOSE BIOSCIENCES INC. | Health Technology |
Aziende private | 2 |
---|---|
High Tech Private Equity GmbH
![]() High Tech Private Equity GmbH Investment ManagersFinance High Tech Private Equity GmbH (HTPE) is a leading German private equity firm controlled by Triginta Capital Group GmbH (formerly AVIDA Equity Partners) and DEWB AG. Established in 1999 and based in Düsseldorf with an office in Liechtenstein, HTPE invests in rapidly growing technology companies and manages the High Tech Beteiligungen fund, backed by institutional investors including German pension funds, banks and insurance companies. | Finance |
ConPharm Anstalt |
- Borsa valori
- Insiders
- George Ludwig